Engi F Attia1, Robert F Miller, Rashida A Ferrand. 1. aPulmonary and Critical Care Medicine, University of Washington, Seattle, Washington, USA bResearch Department of Infection and Population Health, University College London cClinical Research Department, London School of Hygiene and Tropical Medicine, London, UK dBiomedical Research and Training Institute, Harare, Zimbabwe.
Abstract
PURPOSE OF REVIEW: The incidence of pulmonary infections has declined dramatically with improved access to antiretroviral therapy (ART) and cotrimoxazole prophylaxis, but chronic lung disease (CLD) is an increasingly recognized but poorly understood complication in adolescents with perinatally acquired HIV. RECENT FINDINGS: There is a high prevalence of chronic respiratory symptoms, abnormal spirometry and chest radiographic abnormalities among HIV-infected adolescents in sub-Saharan Africa, wherein 90% of the world's HIV-infected children live. The incidence of lymphocytic interstitial pneumonitis, the most common cause of CLD in the pre-ART era, has declined with increased ART access. Small airways disease, particularly constrictive obliterative bronchiolitis and bronchiectasis, are emerging as leading causes of CLD among HIV-infected adolescents in low-income and middle-income countries. Asthma may be more common in high-income settings. Likely risk factors for CLD include recurrent pulmonary infections, air pollution, HIV-related immune dysfunction, and untreated HIV infection, particularly during critical stages of lung development. SUMMARY: Globally, the importance of HIV-associated CLD as a cause of morbidity and mortality is increasing, especially as survival has improved dramatically with ART and growing numbers of children living with HIV enter adolescence. Further research is urgently needed to elucidate the natural history and pathogenesis of CLD, and to determine optimal screening, diagnostic and treatment strategies.
PURPOSE OF REVIEW: The incidence of pulmonary infections has declined dramatically with improved access to antiretroviral therapy (ART) and cotrimoxazole prophylaxis, but chronic lung disease (CLD) is an increasingly recognized but poorly understood complication in adolescents with perinatally acquired HIV. RECENT FINDINGS: There is a high prevalence of chronic respiratory symptoms, abnormal spirometry and chest radiographic abnormalities among HIV-infected adolescents in sub-Saharan Africa, wherein 90% of the world's HIV-infectedchildren live. The incidence of lymphocytic interstitial pneumonitis, the most common cause of CLD in the pre-ART era, has declined with increased ART access. Small airways disease, particularly constrictive obliterative bronchiolitis and bronchiectasis, are emerging as leading causes of CLD among HIV-infected adolescents in low-income and middle-income countries. Asthma may be more common in high-income settings. Likely risk factors for CLD include recurrent pulmonary infections, air pollution, HIV-related immune dysfunction, and untreated HIV infection, particularly during critical stages of lung development. SUMMARY: Globally, the importance of HIV-associated CLD as a cause of morbidity and mortality is increasing, especially as survival has improved dramatically with ART and growing numbers of children living with HIV enter adolescence. Further research is urgently needed to elucidate the natural history and pathogenesis of CLD, and to determine optimal screening, diagnostic and treatment strategies.
Authors: Richard D Pitcher; Carl J Lombard; Mark F Cotton; Stephen J Beningfield; Lesley Workman; Heather J Zar Journal: Thorax Date: 2015-06-09 Impact factor: 9.139
Authors: Kristina Crothers; Bruce W Thompson; Kathryn Burkhardt; Alison Morris; Sonia C Flores; Philip T Diaz; Richard E Chaisson; Gregory D Kirk; William N Rom; Laurence Huang Journal: Proc Am Thorac Soc Date: 2011-06
Authors: Rashida A Ferrand; Lucia Munaiwa; John Matsekete; Tsitsi Bandason; Kusum Nathoo; Chiratidzo E Ndhlovu; Shungu Munyati; Frances M Cowan; Diana M Gibb; Elizabeth L Corbett Journal: Clin Infect Dis Date: 2010-10-01 Impact factor: 9.079
Authors: Alicia A Annamalay; Salome Abbott; Chisha Sikazwe; Siew-Kim Khoo; Joelene Bizzintino; Guicheng Zhang; Ingrid Laing; Glenys R Chidlow; David W Smith; James Gern; Jack Goldblatt; Deborah Lehmann; Robin J Green; Peter N Le Souëf Journal: J Clin Virol Date: 2016-06-04 Impact factor: 3.168
Authors: Sarah Rylance; Jamie Rylance; Grace McHugh; Edith Majonga; Tsitsi Bandason; Hilda Mujuru; Kusum Nathoo; Sarah Rowland-Jones; Marc Y R Henrion; Victoria Simms; Rashida A Ferrand Journal: PLoS One Date: 2019-03-21 Impact factor: 3.240
Authors: Rashida A Ferrand; Grace McHugh; Andrea M Rehman; Hilda Mujuru; Victoria Simms; Edith D Majonga; Mark P Nicol; Trond Flaegstad; Tore J Gutteberg; Carmen Gonzalez-Martinez; Elizabeth L Corbett; Sarah L Rowland-Jones; Katharina Kranzer; Helen A Weiss; Jon O Odland Journal: JAMA Netw Open Date: 2020-12-01
Authors: Kathryn J Snow; Andrea T Cruz; James A Seddon; Rashida A Ferrand; Silvia S Chiang; Jennifer A Hughes; Beate Kampmann; Steve M Graham; Peter J Dodd; Rein M Houben; Justin T Denholm; Susan M Sawyer; Katharina Kranzer Journal: Lancet Child Adolesc Health Date: 2019-11-18
Authors: Sudha Bhadriraju; Douglas W Fadrosh; Susan V Lynch; John Z Metcalfe; Meera K Shenoy; Din L Lin; Kole V Lynch; Kathryn McCauley; Rashida A Ferrand; Edith D Majonga; Grace McHugh; Laurence Huang Journal: Sci Rep Date: 2020-09-30 Impact factor: 4.996